Tackling the trillion dollar Alzheimer’s disease
It’s almost impossible to conceive the complexity that lies ahead in the challenge to address Alzheimer’s disease. But, picture standing in front of an old mansion house, completely overgrown with ivy, trees, and shrubs....
Climate Change and the challenges facing mankind
Climate change is one of the biggest challenges facing mankind. Always has been, always will be, and that means that big changes lie ahead.
Many of those changes will impact on the work of scientists...
Patent Protection of Medical Devices – Time for a Rethink?
Christopher Burnett, Patent Attorney, AA Thornton
The duration of patent protection for medical devices is up to twenty years, as for any other type of device. Pharmaceuticals, on the other hand, may be entitled to an...
Combatting cardiovascular disease today
Cardiovascular disease remains the most common cause of death in the UK and across the world, so in this issue of BioScience Today, Ellen Rossiter speaks to Dr Vijay Kunadian, Senior Lecturer and Honorary...
Making clinical trials right for older people
In this issue, we speak to Miles Witham, Professor of Trials for Older People at Newcastle University and consultant geriatrician, about why he’s bringing about a sea change in how clinical trials involving older...
A golden generation
can the precious metal hold the key to killing cancerous cells?
In the second century A.D., during the Han dynasty, a Chinese author and alchemist known as Wei Boyang is believed to have written: “Gold...
Genome sequencing reveals how salmonella carves out a niche in pork production
Variants of concern (VOCs) and variants of interest (VOIs) have become familiar terms due to the current pandemic, but variants of familiar pathogens such as salmonella also present a threat to human and animal...
Patient capital is the key to unlocking growth in the life sciences sector
By Keith Morgan, CEO, British Business Bank
The British Business Bank, as the UK’s national economic development bank, has a mission to make finance markets for smaller businesses operate more effectively, enabling those businesses to...
Maternal microbiome promotes baby’s healthy development
Researchers studying mice have found the first evidence of how a mother’s gut microbes, the maternal microbiome, can help in the development of the placenta, and the healthy growth of the baby.
Scientists from the...
The scientific, political and economic implications of COVID-19: an insider’s perspective
It is widely assumed that the life science industry performed well off the back of the COVID-19 pandemic, with the demand for assays and molecular tools driving unprecedented sales to support global research. This...
The Nagoya Protocol and the UK – Are you Compliant?
The Nagoya Protocol has been in force in the UK since October 2015 and obliges users of genetic resources and traditional knowledge associated with genetic resources to comply with due diligence requirements before its...
Moving healthcare forward
Making cutting edge treatments accessible to more patients, is one of the greatest challenges facing the healthcare system and biosimilars are playing a part in making this possible. In this issue, we speak to...
Harnessing pharmacogenomics for better health outcomes
In this issue, we speak to Dr Jerika Lam of the School of Pharmacy at Chapman University, about her work applying pharmacogenomics to antiviral treatments.
“A lot has happened in the field of hepatitis C...
Attitudes to work and reward in biotech have changed – and employers … so...
Work in life sciences has never really been about the money, but the mix of qualities that companies offer – and employees want – changes over time. Singular Talent speaks to over 1,500 candidates...
Not gone, not forgotten..
The penny finally drops as politicians pledge support for dementia research
Ironically, given that it is one of the planet’s biggest illnesses, dementia also appeared to creep up on world leaders more focused on other...
UK STRIDES INTO INTERNATIONAL ARENA OF VACCINE DEVELOPMENT
As Oxford University and Imperial College London move into poll position in the race to develop an anti-Covid vaccine, the UK’s first dedicated Vaccines Manufacturing Innovation Centre is preparing to turn their results into...